Ovine-sourced GMI ganglioside reduces motor deficits and elevates BDNF levels in the R6/2 mouse model of Huntington's disease

Research output: Other contribution › peer-review

Original language	English
Publisher	American Society for Neurotherapeutics and Repair
State	Published - Apr 30 2022

Cite this

@misc{6556312e03e84c9fb9e48c02cfd6b6c9,

title = "Ovine-sourced GMI ganglioside reduces motor deficits and elevates BDNF levels in the R6/2 mouse model of Huntington's disease",

author = "Sindhuja Koneru and Sandstrom, {Michael I} and Rossignol, {Julien Pierre Andre} and Gary Dunbar",

year = "2022",

month = apr,

day = "30",

language = "English",

publisher = "American Society for Neurotherapeutics and Repair",

type = "Other",

}